Incannex Healthcare Inc.
For the period ended Jun 30, 2026. Filed Sep 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Sep 25, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: September 25, 2026 | Incannex Healthcare Inc. | |
|---|---|---|
| By: | /s/ Joel Latham | |
| Name: | Joel Latham | |
| Title: | Chief Executive Officer and President |
POWER OF ATTORNEY
IN WITNESS WHEREOF, each person whose signature appears below constitutes and appoints Joel Latham and Joseph Swan as his true and lawful agent, proxy and attorney-in-fact, each acting alone, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to (i) act on and sign any amendments to this report, with exhibits thereto and other documents in connection therewith, (ii) act on and sign such certificates, instruments, agreements and other documents as may be necessary or appropriate in connection therewith, and in each case file the same with the SEC, hereby approving, ratifying and confirming all that such agent, proxy and attorney-in-fact or any of his substitutes may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Name | Position | Date |
|---|---|---|
| /s/ Joel Latham | Chief Executive Officer, President and Director(principal executive officer) | September 25, 2026 |
| Joel Latham | ||
| /s/ Joseph Swan | Chief Financial Officer(principal financial and accounting officer) | September 25, 2026 |
| Joseph Swan | ||
| /s/ Troy Valentine | Director | September 25, 2026 |
| Troy Valentine | ||
| /s/ Peter Widdows | Director | September 25, 2026 |
| Peter Widdows | ||
| /s/ George Anastassov | Director | September 25, 2026 |
| George Anastassov | ||
| /s/ Robert Clark | Director | September 25, 2026 |
| Robert Clark | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.